Company Management Team

CEO and Chief Scientific Officer of the Pierrel Group - Dr. Stephan Henauer, Co-founder

Dr. Henauer is a co-founder of PharmaPart and co-founder of the ADI International Institute for Advancement of Drug Development. Extensive international experience in the pharmaceutical industry (F. Hoffmann-LaRoche and Marion Merrell Dow) as Medical Director, Head of Biostatistics and Data Management and Associate European Medical Director. Author of numerous medical and scientific articles.

MD. degree from the University of Zurich in 1978. Postdoctoral training in clinical pharmacology at Stanford University in California.

Dr. Henauer is a member of the General Management of PharmaPart

CFO - Heide Henauer, Co-founder

Co-founder of PharmaPart and other companies. Twenty years of experience in accounting, personnel and business administration with various international and Swiss companies.

Heide Henauer holds a degree in business administration from the KV Business School in Lucerne and a higher diploma in economics from the HSO in Zurich.

Ms. Henauer is a member of the General Management of PharmaPart

Managing Director (Germany) and Head of Clinical Development - Dr. Wilfried Hauke

Dr. Hauke is a highly experienced clinical research professional with a profound knowledge in the development of new pharmaceutical compounds. Before joining the group in August 2007 he has held increasingly more responsible positions at regulatory authorities as well as in the pharmaceutical and CRO industry. He has worked in an international environment for companies large and small including Hoechst AG, Roussel UCLAF, Charterhouse Clinical Research Unit and EPA Euro Pharma GmbH.

His career spans more than 20 years covering all aspects of clinical research and pharmacovigilance. Dr. Hauke is a member of the German Society of Internal Medicine, the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians, the German Society of Pharmaceutical Medicine, the Drug Information Association (DIA) and of the Paul-Ehrlich Society of Chemotherapy (PEG).

Dr. Hauke completed his studies in medicine at the Ludwig-Maximilian University in Munich and has gained a Doctorate MD awarded by the University of Frankfurt/Main.

Dr. Hauke is a member of the General Management of PharmaPart

Quality Assurance Manager - Geraldine Domeniconi-Dal Pra

Geraldine Domeniconi-Dal Pra has been working in the field of clinical research for almost 15 years, gaining experience in several areas of clinical research, from monitoring to project management, medical writing, training and finally quality assurance, in different therapeutic fields and in national and international trials. She is presently Quality Assurance Manager, being in charge of the internal Quality Assurance and at the same time providing external auditing services tailored to the customer's needs.

Geraldine has a master´s degree in biology of the Federal Technical Institute of Zurich.

Head of Regulatory Affairs - Dr. Nafsika Kronidou

Nafsika Kronidou has been in the field of Regulatory Affairs for more that 11 years. This function includes heading the Pharmacovigilance Unit at PharmaPart. Before joining PhamaPart, Dr Kronidou worked for Novartis for more than 8 years where she held various positions. In her last position she coordinated the worldwide marketing authorization activities for Lucentis, a product authorized via the Centralized procedure in the EU. Prior to this Dr. Kronidou worked as Regulatory Affairs Manager coordinating regulatory activities for products at the early stages of development as well as for the Global labeling group of Novartis. Dr Kronidou also worked for 3 years as an independent consultant for small and medium sized Pharmaceutical companies.

Dr. Kronidou is a cell biologist. She received her Bachelors degree from Bennington College, (Bennington, Vermont) and a PhD from Dartmouth College (Hanover, New Hampshire), both in the USA. She participated in a two-year post-doctoral project at the Biocenter of the University of Basel in Switzerland and received a Masters degree in Pharmaceutical Medicine from the University of Witten/Herdecke in Germany.

Head of Statistics and Data Management - Uwe Hehnke

Uwe Hehnke is a highly experienced statistics and data management professional with more than 20 years experience within the pharmaceutical and CRO environment. During this time, he has assumed various responsibilities including project statistician, head of clinical data management and director of biometrics.

He began his career at a small CRO in Cologne. Afterwards, he spent some time with Behringwerke in Marburg, and moved from there to Ciba-Geigy (now Novartis) in Basel, where he worked for six years as a project statistician. Mr. Hehnke spent the following ten years with Abbott/Knoll in Ludwigshafen as a project statistician, and later as head of clinical data management. From 2002 to 2007 Mr. Hehnke was the director of international biostatistics and data management at EPA Euro Pharma, later on he joined the Premier Research group, in Darmstadt. In February 2007 Mr. Hehnke joined PharmaPart as the director of biometrics.

During his time at Ciba-Geigy Abbott/Knoll and EPA/Premier Research, Mr. Hehnke gained practical experience in nearly all the main therapeutic areas.

Mr Hehnke hold professional membership with the International Biometrical Society and the biostatistical working group of the German Pharmaceutical Industry.

Director of Sales - Dr. Manfred Rohde

Manfred Rohde, educated as a pharmacist, started his career as Regulatory Affairs Manager at Upjohn. After nearly 20 years in Clinical Research and in Sales and Marketing at the Hoechst Group ( Hoechst, Hoechst Marion Roussel) Dr. Rohde left the pharmaceutical industry as the Director Marketing Antiinfectives Germany.

As part of a competent management team Dr. Rohde successfully developed a German CRO during the past decade. In 2006 he joined PharmaPart as Director Sales for Germany, Switzerland and Austria.

Manfred Rohde, graduated as a pharmacist at the University of Bonn.

Team Leader Regulatory Affairs Germany - Manfred Schlemminger

Manfred Schlemminger has been in the field of Regulatory Affairs for more than 20 years and is presently responsible for five employees. He is furthermore the acting Qualified Person for Pharmacovigilance and Control. He was previously employed by the Cyanamid Group where he assumed the position of Manager of Drug Regulatory Affairs. He had additional functions as Deputy Commissioner of the Graduated Plan (Qualified Person for Pharmacovigilance) at the Cyanamid Group and as such was responsible for the collection, evaluation and documentation of all reports of drug risk as well as the coordination of subsequent measures to be taken and the notification of relevant authorities.

Manfred Schlemminger studied chemistry and pharmacy at the Ludwig-Maximilian University of Munich from which he was awarded the licence to practise pharmacy in 1977. He is a member of the Landesapothekerkammer Hessen.

Director Marketing - Brian Rees

Mr. Rees has a background in the computing and communications industries. During the last 35 years he has held a number of key marketing positions with a number of companies. He has been active in a number of fields including: software development, university grant programmes ,AI, virtual reality, load balancing systems, middleware and applications for mobile phones.

Mr. Rees has come to the pharmaceutical industry late in life but finds the business an interesting challenge.